aod9604 fda status ✓ The has repeatedly flagged AOD-9604 as a compound of concern. It was placed on the Category 2 list in 2023 — bulk drug substances in compounding that may present significant AOD-9604 Peptide in Ocala, FL
AOD 9604 Peptide in Ocala, FL Padgett Medical Center AOD 9604: Weight Loss, Evidence, Safety & Legal Status Peptide Skin Science FDA to Review Peptides Backed by RFK Jr for Compounding Pharmacies Full story & link in the comments Buy AOD 9604 5mg Research Peptide Vial for Lab Use
Pay in 4 interest-free payments of $6.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


